Department of Health and Social Care

“| have passed your concerns regarding the nursing pillow on to OPSS's Product Safety Enforcement Team but in order to investigate further they have asked that any details you have of the specific product involved, including information about the distributor be shared with them. If you have any further information that would assist their assessment, | would be grateful if you could pass it directly to [name redacted], Chief Executive, OPSS, Victoria Square House, Birmingham B2 4AJ. This would”

“In March 2018, Public Health England (PHE) and The Lullaby Trust jointly published guidance to help new and expectant parents make safer choices when deciding on sleeping products for their baby”

“In my opinion action should be taken to prevent future deaths and | believe you and your organisation have the power to take such action.”

“My officials have made enquiries with a number of bodies on the matter of concern in your report that there should be routine therapeutic blood monitoring (testing of blood plasma levels) in patients who are prescribed clozapine.”

“opportunity to raise awareness of this incident with industry stakeholders, underlining the importance of all people involved in event organising and planning to adhere to the standards set out in guidance.”

“My officials have contacted the Principal Inspector at the Health and Safety Executive (HSE) to inform him of your letter.”

“My officials have made enquiries with NHS England on the matter of concern in your report.”

“issue an advisory alert to bring this area of concern to the attention of renal units in England and ask that they review their current practices, paying particular attention to precautions such as pressure being applied to the exit site for no less than 15 minutes and a period of bed rest post procedure of no less than an hour”

“We stand ready to support the MHRA in ensuring any future changes to monitoring reach all appropriate healthcare professionals and patients, including through our shared national network of Medication Safety Officers.”

“We have further considered your concerns that there may be other dependent persons suffering from lupus (or other conditions for which hydroxychloroquine is prescribed in NHS hospitals in England and Wales) who may also have toxic levels of hydroxychloroquine in their system unbeknown to their carers. Some”